A Multi-Centre Randomised Clinical Trial of Biomarker-Driven Maintenance Treatment for First-Line Metastatic Colorectal Cancer (MODUL)
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2018
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary) ; Capecitabine (Primary) ; Vemurafenib (Primary) ; Cetuximab; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms MODUL
- Sponsors Roche
- 05 Apr 2018 Status changed from recruiting to suspended.
- 29 Mar 2018 This trial has been suspended in Slovenia.
- 15 Mar 2018 Planned End Date changed from 30 Oct 2020 to 29 Dec 2021.